Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities
Journal of Cancer · 01.01.2026 · 17 (2) · 290-299
DOI: 10.7150/jca.122078 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cancer, erschienen am 01.01.2026. Verfasst von Chengyuan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029, China.
Zitieren
APA
Li, C., Zhou, J., Zhang, L., Si, Y., Zhang, X., & Shen, M. (2026). Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities. Journal of Cancer, 17(2), 290-299. https://doi.org/10.7150/jca.122078
Vancouver
Li C, Zhou J, Zhang L, Si Y, Zhang X, Shen M. Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities. Journal of Cancer. 2026;17(2):290-299. doi:10.7150/jca.122078
BibTeX
@article{Li2026,
author = {Li, Chengyuan and Zhou, Jianing and Zhang, Lijun and Si, Yan and Zhang, Xiang and Shen, Meiping},
title = {Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities},
journal = {Journal of Cancer},
year = {2026},
volume = {17},
number = {2},
pages = {290--299},
doi = {10.7150/jca.122078}
}
EUVIMED